In this study, the evidence suggests that IL17RC increases AMD risk via two pathways, alternative complement pathway and insensitivity of PI3K/Akt/GSK3 (delinked regulation by stimuli) resulting in increased GSK3 activity (Figure 6). Here, AKT1 is linked to age-related macular degeneration.